Results 11 to 20 of about 600,930 (299)

Antibody-mediated central nervous system diseases [PDF]

open access: yesBrain and Neuroscience Advances, 2018
Antibody-mediated central nervous system diseases are a relatively new area of clinical neuroscience with growing impact. Their recognition has challenged the dogma of the blood–brain barrier preventing antibody access into the central nervous system ...
Maria Pia Giannoccaro   +2 more
doaj   +4 more sources

Central nervous system manifestations in rheumatic diseases [PDF]

open access: yesJournal of Medical Biochemistry, 2011
Neurological involvement is associated with significant morbidity in patients with rheumatic diseases, and may indicate heightened disease activity. Connective tissue diseases result from immunologic or autoimmune reactions.
Cojocaru Mihaela Inimioara   +3 more
doaj   +2 more sources

Microglia lactylation in relation to central nervous system diseases [PDF]

open access: yesNeural Regeneration Research
The development of neurodegenerative diseases is closely related to the disruption of central nervous system homeostasis. Microglia, as innate immune cells, play important roles in the maintenance of central nervous system homeostasis, injury response ...
Hui Yang   +7 more
doaj   +2 more sources

Central nervous system Whipple's disease [PDF]

open access: yesAnnals of Neurology, 1997
Contains fulltext : 25412___.PDF (Publisher’s version ) (Open Access)
Verhagen, W.I.M.   +2 more
openaire   +4 more sources

Brainstem syndrome at onset is related to an early MS diagnosis in Peru: A national referral center cohort

open access: yesHeliyon, 2021
Background: MS is unpredictable regarding clinical symptoms; however, certain symptoms represent the preferred localization of white matter lesions such as brainstem, spinal cord; or optic nerve.
César Caparó-Zamalloa   +6 more
doaj   +1 more source

Effects of the mGlu2/3 receptor agonist LY379268 on two models of disturbed auditory evoked brain oscillations in mice

open access: yesTranslational Psychiatry, 2023
Cognitive impairment is a core feature of schizophrenia and is poorly addressed by currently available medication. This is partly because the underlying circuits are insufficiently understood, and available animal models for brain dysfunction do not ...
Oana-Daniela Dormann   +2 more
doaj   +1 more source

RETRACTED ARTICLE: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death

open access: yesCell Death and Disease, 2021
Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor for which new therapeutic approaches are urgently required. Unfolded protein response (UPR) plays an important role in the progression of GBM and is a promising target for developing ...
Guanzheng Liu   +13 more
doaj   +1 more source

Effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With Neuromyelitis Optica Spectrum Disorder

open access: yesFrontiers in Immunology, 2021
Tocilizumab, a humanized anti-IL-6 receptor monoclonal antibody, showed its therapeutic efficacy on neuromyelitis optica spectrum disorder (NMOSD).
Ye Liu   +12 more
doaj   +1 more source

Exploration of cerebral vasospasm from the perspective of microparticles

open access: yesFrontiers in Neuroscience, 2022
Cerebral vasospasm is a frequently encountered clinical problem, especially in patients with traumatic brain injury and subarachnoid hemorrhage. Continued cerebral vasospasm can cause cerebral ischemia, even infarction and delayed ischemic neurologic ...
Yalong Gao   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy